These results suggest a potential implications of mGluR5 NAM LCGM-10 for the treatment of movement disorders, ADHD, OCD, and pathological conditions associated with impulsive behavior (drug addiction and gambling). The gene discussed is GRM5; the disease is attention deficit-hyperactivity disorder.